Navigation Links
University of Minnesota chemist named 1 of Popular Science's 'Brilliant 10'
Date:9/11/2012

MINNEAPOLIS / ST. PAUL (09/11/2012) University of Minnesota chemist Christy Haynes has been named one of Popular Science magazine's "Brilliant 10," an honor that recognizes an elite group of young scientists whose research is expected to dramatically impact their fields. Haynes' profile was published today on the PopSci website and is featured in the Popular Science magazine now on newsstands.

Haynes, an associate professor of chemistry in the University's College of Science and Engineering, has been working with her research group to study blood platelets. Platelets are small, irregularly shaped cell fragments that circulate in the blood and are an essential component of blood clotting. Platelets are about one-tenth the size of average cells in mammals and have proven difficult to study due their small size and their biological function to react immediately when in a foreign environment.

"Platelets are really 'sticky' types of cells because they are used in clotting so it makes them difficult to study," Haynes said.

Haynes and her team are the only researchers in the world who have been able to measure chemicals being released by individual platelets in real time. They were the first to successfully isolate an individual platelet under a microscope, place a minuscule electrode onto it, and measure the messenger molecules released.

Understanding how platelets communicate with each other gives researchers fundamental knowledge they never had before. This could lead to new treatments for patients who have difficulty with blood clotting or developing medications to help patients avoid dangerous blood clots.

Haynes is already collaborating with renowned platelet specialists nationwide to look at platelet samples and conduct initial lab testing for possible anti-clotting medicines.

"Being chosen as one of Popular Science's Brilliant 10 brings new recognition to the graduate students on my research team and my fellow researchers to show that there is big science and big thinking going on here at the University of Minnesota," Haynes said.

Haynes and her colleagues recently formed the Center for Analysis of Biomolecular Signalling within the University of Minnesota Department of Chemistry. The research will be focused on learning more about how cells in the body send chemical signals to each other during immune response, blood clotting, muscle firing and more.

In addition to studying platelets, Haynes has been building "an immune system on a chip," where she is isolating and studying the various way cells communicate and respond to each other. With more information about how immune cells interact, she helps to open new avenues for treating allergic reactions and asthma.

"This recognition of Christy's groundbreaking work is certainly well-deserved," said University of Minnesota Department of Chemistry Chair William Tolman. "Her creativity, attention to detail, and outstanding communication and leadership skills underlie her success as a faculty member and scientist."


'/>"/>
Contact: Rhonda Zurn
rzurn@umn.edu
612-626-7959
University of Minnesota
Source:Eurekalert

Related medicine news :

1. University of Maryland study: Neonatal heart stem cells may help mend kids broken hearts
2. Aarhus University to inaugurate the ultimate source of light:
3. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
4. University of Hawaii cancer researchers discover gene defect responsible for cancer syndrome
5. Oxford University Press acquires American Journal of Hypertension
6. Queens University Belfast wins national environment award
7. Non-invasive treatment for children with obstructive sleep apnea suggested by Ben-Gurion University study
8. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
9. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
10. University of Pennsylvania and Novartis form alliance to expand use of personalized T cell cancer therapy
11. Boston University researchers expand synthetic biologys toolkit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: